FDA 510(k)

Injection de chlorure de sodium 0,9 %, USP BD PosiFlush™ SF Saline Flush Seringue

Numéro K : K231161 · 2023-07-21

Date de décision2023-07-21

Code produitNGT

Comité consultatifHO

DécisionSubstantially Equivalent

Résumé du dispositif

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2023-07-21 under 510(k) number K231161. The device is classified under product code NGT. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is a medical device that received FDA 510(k) clearance on 2023-07-21. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K231161.

When did 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe receive FDA 510(k) clearance?

0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe received FDA 510(k) clearance on 2023-07-21, under 510(k) number K231161.

Who is the listed applicant for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe?

The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush™ SF Saline Flush Syringe is NGT.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant Becton, Dickinson and Company en tant que demandeur

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K260184Onclarity™ Self-Collection Kit K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes

Voir tous les 102 dispositifs →

Dispositifs connexes (Code : NGT)

K250884Injection de chlorure de sodium 0,9 %, USP, seringue BD PosiFlush™ SPBecton, Dickinson and Company K233623Praxiject™ SP 0.9% NaClMedxl, Inc.K231724Flush Syringe (Prefilled 0.9% normal saline solution)Spm Medicare Pvt. , Ltd.K231363Hantech Pre-filled 0.9% Normal Saline Flush Syringes (Models PFS-1003, PFS-1005, PFS-1010)Hantech Medical Device Co., Ltd.K223584Pre-Filled Normal Saline Flush SyringeAnhui Tianyang Pharmaceutical Co., Ltd.K230756TK Pre-Filled Normal Saline Flush SyringeAnhui Tiankang Medical Technology Co., Ltd.

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.